Ventyx Biosciences, Inc. logo

Ventyx Biosciences, Inc.

NASDAQ:VTYX

Overview | Financials
Company Name Ventyx Biosciences, Inc.
Symbol VTYX
Currency USD
Price 2.29
Market Cap 161,832,308
Dividend Yield 0%
52-week-range 1.79 - 38.05
Industry Biotechnology
Sector Healthcare
CEO Dr. Raju S. Mohan Ph.D.
Website https://www.ventyxbio.com

An error occurred while fetching data.

About Ventyx Biosciences, Inc.

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease,

Related Stocks

SNDL Inc. logo

SNDL Inc.

SNDL

2.13 USD

Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

RXRX

6.91 USD

Simulations Plus, Inc. logo

Simulations Plus, Inc.

SLP

31.45 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

11.03 USD

Revance Therapeutics, Inc. logo

Revance Therapeutics, Inc.

RVNC

5.99 USD

BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BBIO

25.96 USD

Sharecare, Inc. logo

Sharecare, Inc.

SHCR

1.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD